Resumen de SEOM clinical guideline in nasopharynx cancer (2017)

Miguel Pastor Borgoñón, Antonio López Pousa, Edel del Barco Morillo, Pedro Pérez Segura, Beatriz González Astorga, Beatriz Castelo Fernández, Teresa Bonfill Abella, Javier Martínez Trufero, Juan J. Grau de Castro, Ricard Mesía Nin

• Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiation therapy is an essential component of curative-intent of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.